Late line FOLFOX therapy after prior cisplatin-based regimen in advanced esophageal squamous cell carcinoma: A multi-institutional retrospective study

被引：0

作者：

Shimozaki, K. ^{[1
]}

Sugiyama, K. ^{[2
]}

Koya, S. ^{[3
]}

Shiraishi, K. ^{[2
]}

Okada, M. ^{[4
]}

Matsubara, Y. ^{[5
]}

Furuta, M. ^{[6
]}

Hirose, S. ^{[7
]}

Komori, A. ^{[8
]}

Mitani, S. ^{[9
]}

Boku, S. ^{[10
]}

Nishimura, T. ^{[11
]}

Tsuchihashi, K. ^{[12
]}

Kito, Y. ^{[13
]}

Sugaya, A. ^{[14
]}

Masuishi, T. ^{[15
]}

Matsumoto, T. ^{[16
]}

Tsuzuki, T. ^{[17
]}

Yoshii, T. ^{[18
]}

Hirata, K. ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Internal Med Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo, Japan

[2] Nagoya Med Ctr, Natl Hosp Org, Dept Med Oncol, Nagoya, Aichi, Japan

[3] Tonan Hosp, Med Oncol, Sapporo, Hokkaido, Japan

[4] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Chuo Ku, Tokyo, Japan

[5] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[6] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Kanagawa, Japan

[7] Univ Tsukuba, Div Gastroenterol, Fac Med, Tsukuba, Ibaraki, Japan

[8] Natl Hosp Org Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime, Japan

[9] Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan

[10] Kansai Med Univ, Canc Treatment Ctr, Hirakata, Osaka, Japan

[11] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan

[12] Kyushu Univ, Grad Sch Med Sci, Fac Med Sci, Hematol Oncol & Cardiovasc Med, Fukuoka, Japan

[13] Ishikawa Prefectural Cent Hosp, Dept Med Oncol, Kanazawa, Ishikawa, Japan

[14] Baraki Prefectural Cent Hosp, Div Gastroenterol, Tsukuba, Ibaraki, Japan

[15] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[16] Kobe City Med Ctr, Gen Hosp, Dept Med Oncol, Dept Internal Med, Kobe, Hyogo, Japan

[17] Japanese Red Cross Soc Himeji Hosp, Dept Internal Med, Himeji, Hyogo, Japan

[18] Saitama Canc Ctr, Dept Gastroenterol, Ina, Saitama, Japan

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.10.162

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

126P

引用

页码：S1481 / S1481

页数：1

共 50 条

[21] Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinoma
Fang, Min
Song, Tao
Liang, Xiaodong
Lv, Shiliang
Li, Jianbo
Xu, Hong'en
Luo, Limin
Jia, Yongshi
[J]. ONCOTARGET, 2017, 8 (23) : 37080 - 37090
[22] Cetuximab-Based Bioradiation Therapy Versus Cisplatin-Based Chemoradiation Therapy in the Definitive Treatment of Locally Advanced Oropharyngeal Squamous Cell Carcinoma
Bhattasali, O.
Iganej, S.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S82 - S83
[23] A clinical comparison of short-term efficacy, survival and adverse reactions between raltitrexed/cisplatin-based and docetaxel/cisplatin-based concurrent chemoradiotherapy in the treatment of advanced esophageal squamous cell carcinoma
Gong, Xin-Lei
Sun, Xin-Chen
Ge, Xiao-Lin
Wang, Yao
[J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 (04) : 798 - 805
[24] A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: A Japanese retrospective multi-institutional study.
Inoue, Takamitsu
Miyazaki, Jun
Ichioka, Daishi
Narita, Shintaro
Kageyama, Susumu
Sugimoto, Mikio
Mitsuzuka, Koji
Kinoshita, Hidefumi
Kikuchi, Eiji
Matsui, Yoshiyuki
Fujie, Keiko
Habuchi, Tomonori
Nishiyama, Hiroyuki
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[25] USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin-based therapy
Wei, Bin
Xu, Lijuan
Hui, Hongxia
Sun, Yuan
Wu, Jingjing
[J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (06) : 932 - 938
[26] A Retrospective Multi-institutional Study of Proton Beam Therapy for Head and Neck Cancer With Non-Squamous Cell Histologies
Akimoto, T.
Zenda, S.
Nakamura, N.
Demizu, Y.
Okimoto, T.
Murayama, S.
Mizumoto, M.
Sakurai, H.
Nakamura, T.
Kikuchi, Y.
Yamamoto, K.
Shirato, H.
Onoe, T.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E337 - E337
[27] Navigation of patients with locally advanced head and neck squamous cell carcinoma during cisplatin-based chemoradiation: A cohort study.
De Castro, Gilberto
De Souza, Priscila Rangel
Ruggiero Nunes, Lenira Corsi
Josefa Souza, Rosilene
Vieira Dias, Tamara Aparecida
Dos Reis, Nathalia
Goes, Samira S.
Moravia, Renata Alvim
Fantinato Moreira, Paulo Thadeu
Mendoza Lopez, Rossana Veronica
Da Silva, Maria Rita
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18613 - E18613
[28] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
Jeeyun Lee
Young-Hyuck Im
Eun Yoon Cho
Yong Sang Hong
Hyo Rak Lee
Hyo Song Kim
Mi-Jin Kim
Kwhanmien Kim
Won Ki Kang
Keunchil Park
Young Mog Shim
[J]. Cancer Chemotherapy and Pharmacology, 2008, 62 : 77 - 84
[29] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
Lee, Jeeyun
Im, Young-Hyuck
Cho, Eun Yoon
Hong, Yong Sang
Lee, Hyo Rak
Kim, Hyo Song
Kim, Mi-Jin
Kim, Kwhanmien
Kang, Won Ki
Park, Keunchil
Shim, Young Mog
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 77 - 84
[30] Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society
Suzuki, Takashi
Yajima, Satoshi
Okamura, Akihiko
Yoshida, Naoya
Taniyama, Yusuke
Murakami, Kentaro
Ohkura, Yu
Nakajima, Yasuaki
Yagi, Koichi
Fukuda, Takashi
Ogawa, Ryo
Hoshino, Isamu
Kunisaki, Chikara
Narumiya, Kosuke
Tsubosa, Yasuhiro
Yamada, Kazuhiko
Shimada, Hideaki
[J]. ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 30 (01)

← 1 2 3 4 5 →